Supplementary Methods from Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells &lt;i&gt;In vitro&lt;/i&gt; and Controls Tumor Expansion &lt;i&gt;In vivo&lt;/i&gt; via Low-Affinity Activating Fcγ Receptors